Applications of iPS-Cell Derived Tissues in Safety Assessment (Applications of iPS-Cell Derived Tissues in Safety Assessment)
Owner/Developer: American College of Toxicology (ACT)
United States of America
17 September 2015
The ability to make pluripotent stem cells from adult somatic cells has revolutionized cell biology, especially as access to differentiated tissues from induced pluripotent stem cells has improved. Differentiated cells from induced pluripotent cell are more similar to intact tissue than cell lines or primary culture and rodents thus have begun to change the standard models to more human in vitro-based models.
In this talk, I will highlight the numerous examples where stem cell-derived tissues have replaced, refined, and/or reduced the reliance on animal models in drug screening, toxicology, and product safety.
Optional / Voluntary
1 h 2 min
Students, Researchers, Regulators and policy-makers, Teachers and educators, Technicians, Managers, Scientific officers / Project managers, Professionals (e.g. veterinarians), General public
Academia, Industry, Governmental bodies, Contract Research Organizations (CROs), Consulting, SMEs
Continuing Professional Development
Refinement, Reduction, Replacement
In vitro methods
Full coverage (a dedicated course)
|Details on the topic or technology covered:||
|Accreditation body and/or authority that approved the education or training:||
In collaboration with: British Toxicology Society, SOT Stem Cells Specialty Section,
Society of Toxicologic Pathology, and the Teratology Society
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.